Article
Heterozygosity for the alpha1-antitrypsin Z allele may confer genetic risk of cholangiocarcinoma.
Alimentary pharmacology & therapeutics - 1 Feb 2011
Mihalache F, Höblinger A, Grünhage F, Krawczyk M, Gärtner B C, Acalovschi M, Sauerbruch T, Lammert F, Zimmer V
Abstract excerpt
BACKGROUND: Alpha1-antitrypsin (α1AT) deficiency caused by Z allele homozygosity represents a well-established risk factor for hepatocellular carcinoma. Previous studies have also implicated α1AT Z heterozygosity in cholangiocarcinogenesis. AIM: To assess the 'common' Z and S alleles as well as the promoter variant rs8004738 for association with cholangiocarcinoma. METHODS: We genotyped 182 Caucasian patients and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
